Transarterial Radioembolization

Known as: TARE 
A treatment for hepatocellular carcinoma that uses radioactive microspheres to both cause hepatic artery embolization and to deliver regional… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives.
In the last decade trans-arterial radioembolization has given promising results in the treatment of patients with intermediate or… (More)
  • table 1
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.
BACKGROUND & AIMS Transarterial chemoembolisation (TACE) improves survival of properly selected patients with hepatocellular… (More)
  • table 1
  • figure 4
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma.
BACKGROUND In Japan and South Korea, transarterial chemoembolisation (TACE) is an important locoregional treatment for patients… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Research reporting standards for radioembolization of hepatic malignancies.
Riad Salem, MD, MBA, Robert J. Lewandowski, MD, Vanessa L. Gates, MS, Charles W. Nutting, DO, Ravi Murthy, MD, Steven C. Rose, MD… (More)
  • table 1
  • table 2
  • table 3
  • table 3
  • table 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization.
Chemoembolization and other ablative therapies are routinely utilized in downstaging from United Network for Organ Sharing (UNOS… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma with Drug Eluting Beads: Results of an Open-Label Study of 62 Patients
The purpose of this study was to assess the safety and efficacy of doxorubicin-loaded beads (DC Beads) delivered by transarterial… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
BACKGROUND & AIMS To elucidate the survival of the patients with unresectable hepatocellular carcinoma (HCC) who underwent… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival.
Context Few studies address long-term outcomes of antiviral therapy for patients with chronic hepatitis C and cirrhosis… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus.
Context Hepatocellular carcinoma often follows hepatitis C virus infection. Currently available treatments for hepatocellular… (More)
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters.
OBJECTIVE To determine the long-term results of liver transplantation for hepatocellular carcinoma (HCC) measuring 5 cm or larger… (More)
Is this relevant?